tiprankstipranks
Trending News
More News >
Positive Outlook for Ligand Pharma: Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatingsPositive Outlook for Ligand Pharma: Strong Financial Performance and Strategic Positioning Justify Buy Rating
1M ago
Ligand sees FY25 adjusted EPS $6.00-$6.25, consensus $6.11
Premium
The Fly
Ligand sees FY25 adjusted EPS $6.00-$6.25, consensus $6.11
1M ago
Ligand reports Q1 adjusted EPS $1.33, consensus $1.21
Premium
The Fly
Ligand reports Q1 adjusted EPS $1.33, consensus $1.21
1M ago
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
PremiumCompany AnnouncementsLigand Pharmaceuticals’ Earnings Call Highlights Strong Growth
4M ago
Ligand price target raised to $155 from $143 at RBC Capital
Premium
The Fly
Ligand price target raised to $155 from $143 at RBC Capital
4M ago
Ligand Pharmaceuticals Reports Strong 2024 Financial Growth
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong 2024 Financial Growth
4M ago
Ligand Pharmaceuticals Inc (LGND) Q4 Earnings Cheat Sheet
PremiumPre-EarningsLigand Pharmaceuticals Inc (LGND) Q4 Earnings Cheat Sheet
4M ago
Ligand price target raised to $160 from $150 at Barclays
Premium
The Fly
Ligand price target raised to $160 from $150 at Barclays
6M ago
Ligand price target raised to $143 from $141 at RBC Capital
Premium
The Fly
Ligand price target raised to $143 from $141 at RBC Capital
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100